| Ms Farideh Ghasemi, FNP | |
|
11705 Slate Ave, #200, Riverside, CA 92505 | |
| (800) 274-3893 | |
| (951) 359-1999 |
| Full Name | Ms Farideh Ghasemi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 11705 Slate Ave, Riverside, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023190014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 16641 (California) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | NP16641 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Arrowhead Regional Medical Center | Colton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Quantum Healthcare Medical Associates Inc | 5294647574 | 93 |
News Archive
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. in the United States District Court for the Northern District of Illinois in Chicago. XenoTech and Sekisui Medical are wholly-owned subsidiaries of Sekisui Chemical.
Residents on Chicago's South Side have identified chronic diseases, the need for violence prevention and trauma resiliency, and health inequities as key health concerns that they face, according to the University of Chicago Medicine's 2019 Community Health Needs Assessment.
A pioneering study reports on the interaction of a tailored titanium oxide nanoparticle (NP) with the full-length SARS-CoV-2 non-structural protein 1 (nsp1). This should be of value in developing new therapeutic tools against coronaviruses that act by targeting their proteins. It could also help map the structure of activated proteins.
UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
› Verified 3 days ago
| Entity Name | Quantum Healthcare Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568490597 PECOS PAC ID: 5294647574 Enrollment ID: O20040924000422 |
News Archive
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. in the United States District Court for the Northern District of Illinois in Chicago. XenoTech and Sekisui Medical are wholly-owned subsidiaries of Sekisui Chemical.
Residents on Chicago's South Side have identified chronic diseases, the need for violence prevention and trauma resiliency, and health inequities as key health concerns that they face, according to the University of Chicago Medicine's 2019 Community Health Needs Assessment.
A pioneering study reports on the interaction of a tailored titanium oxide nanoparticle (NP) with the full-length SARS-CoV-2 non-structural protein 1 (nsp1). This should be of value in developing new therapeutic tools against coronaviruses that act by targeting their proteins. It could also help map the structure of activated proteins.
UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Farideh Ghasemi, FNP 11705 Slate Ave, #200, Riverside, CA 92505 Ph: (800) 274-3893 | Ms Farideh Ghasemi, FNP 11705 Slate Ave, #200, Riverside, CA 92505 Ph: (800) 274-3893 |
News Archive
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. in the United States District Court for the Northern District of Illinois in Chicago. XenoTech and Sekisui Medical are wholly-owned subsidiaries of Sekisui Chemical.
Residents on Chicago's South Side have identified chronic diseases, the need for violence prevention and trauma resiliency, and health inequities as key health concerns that they face, according to the University of Chicago Medicine's 2019 Community Health Needs Assessment.
A pioneering study reports on the interaction of a tailored titanium oxide nanoparticle (NP) with the full-length SARS-CoV-2 non-structural protein 1 (nsp1). This should be of value in developing new therapeutic tools against coronaviruses that act by targeting their proteins. It could also help map the structure of activated proteins.
UK hospital evaluation cites ‘revolution' with 16% sensitivity uplift in true positive rates. Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS Trust, using the Aplio i700 ultrasound system with ‘Smart Fusion' application.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
› Verified 3 days ago
Alice Chinyere Echeta, FNP, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4960 Arlington Ave Ste B, Riverside, CA 92504 Phone: 951-341-8930 | |
Obianuju Rivera, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3801 University Ave Ste 270, Riverside, CA 92501 Phone: 855-427-2778 Fax: 951-530-3997 | |
Luamy Gabriela Cornejo, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4440 Brockton Ave Ste 100, Riverside, CA 92501 Phone: 951-684-1293 | |
Christine Pham Duong, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5549 Van Buren Blvd, Riverside, CA 92503 Phone: 951-324-5901 Fax: 877-778-9472 | |
Namrata Nicole Sihotang, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 19330 Jesse Ln Ste 100, Riverside, CA 92508 Phone: 844-827-8000 | |
Helen Landayan Lo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7140 Indiana Avenue, Riverside, CA 92503 Phone: 951-358-6037 | |
Rebecca J Seawell, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 |